BILLERICA, Mass.--(BUSINESS WIRE)--Bruker BioSciences Corporation (Nasdaq: BRKR) today closed its public offering of 11,960,000 shares of its common stock, of which 2,530,000 shares were sold by the Company and 9,430,000 shares were sold by four selling stockholders at $7.10 per share. The total shares sold include 1,560,000 shares of common stock (330,000 shares from the Company and 1,230,000 shares from the selling stockholders) sold pursuant to the underwriters’ exercise in full of their over-allotment option.
